Letter to the Editor: 'High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor-associated hypophysitis (CORTICI): an open, randomized controlled trial'
- PMID: 40231495
- PMCID: PMC12001839
- DOI: 10.1080/07853890.2025.2491661
Letter to the Editor: 'High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor-associated hypophysitis (CORTICI): an open, randomized controlled trial'
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Similar articles
-
Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.J Immunother Cancer. 2019 Sep 12;7(1):248. doi: 10.1186/s40425-019-0729-3. J Immunother Cancer. 2019. PMID: 31511065 Free PMC article.
-
Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review.Clin Endocrinol (Oxf). 2016 Sep;85(3):331-9. doi: 10.1111/cen.13063. Epub 2016 Apr 13. Clin Endocrinol (Oxf). 2016. PMID: 26998595 Review.
-
MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis.AJNR Am J Neuroradiol. 2020 Sep;41(9):1683-1689. doi: 10.3174/ajnr.A6692. Epub 2020 Aug 6. AJNR Am J Neuroradiol. 2020. PMID: 32763900 Free PMC article.
-
High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma.Cancer. 2018 Sep 15;124(18):3706-3714. doi: 10.1002/cncr.31629. Epub 2018 Jul 5. Cancer. 2018. PMID: 29975414
-
A Novel Etiology of Hypophysitis: Immune Checkpoint Inhibitors.Endocrinol Metab Clin North Am. 2020 Sep;49(3):387-399. doi: 10.1016/j.ecl.2020.05.002. Epub 2020 Jul 15. Endocrinol Metab Clin North Am. 2020. PMID: 32741478 Review.
References
-
- Theiler-Schwetz V, Trummer C, Schmitt L, et al. . High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomized controlled trial. Ann Med. 2025; Dec57(1):2453829. doi: 10.1080/07853890.2025.2453829. - DOI - PMC - PubMed
-
- Zylla DM, Gilmore G, Eklund J, et al. Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy - PubMed
LinkOut - more resources
Full Text Sources